News Releases

  • Email
  • Print
  • Share
  • Text
Highlight Glossary Terms

News tagged ‘chemotherapy’ clear

  • Adding Avastin to standard chemotherapy treatment may not improve survival rates for people with non-small cell lung cancer aged 65 plus, according to Dana-Farber researchers, who further suggest that clinicians exercise caution in including the drug in treatment recommendations.

Tags: chemotherapy, LungCancer

  • In a nationwide study of women with triple-negative breast cancer, adding the chemotherapy drug carboplatin or the angiogenesis inhibitor Avastin to standard chemotherapy drugs brought a sharp increase in the number of patients whose tumors shrank away completely.

Tags: chemotherapy, BreastCancer

  • A combination of chemotherapies for colon cancer decreases recurrence for patients under 70, but not for those who are older, according to Mayo Clinic and Dana-Farber scientists.

Tags: chemotherapy, BasicResearch, ColonCancer

  • In a new study, women with relatively small, HER2-positive breast tumors who received a combination of lower-intensity chemotherapy and a targeted therapy following surgery or radiation therapy were very unlikely to have the cancer recur within a few years of treatment.

Tags: chemotherapy, BreastCancer, TargetedTherapy

  • Researchers from Dana-Farber Cancer Institute will be presenting more than 70 studies at this year’s annual meeting of the American Society of Clinical Oncology (ASCO) in Chicago, May 29 – June 2, 2015.

Tags: chemotherapy, BreastCancer

  • A national drug shortage has been linked to a higher rate of relapse among Hodgkin lymphoma patients enrolled in a national pediatric clinical trial, report researchers involved in the study.

Tags: chemotherapy, ChildhoodCancer, Lymphoma

  • Based on results of a clinical trial led by Dana-Farber Cancer Institute scientists, the U.S. Food and Drug Administration (FDA) approved a targeted drug for advanced stomach cancer.

Tags: chemotherapy, TargetedTherapy

  • Pediatric patients with B-precursor acute lymphoblastic leukemia who are likely to relapse after chemotherapy treatment can reduce those odds by receiving additional courses of chemotherapy, according to research by Dana-Farber/Children's Hospital Cancer Center investigators.

Tags: chemotherapy, ChildhoodCancer, Leukemia

  • Children with acute lymphoblastic leukemia (ALL), the most common form of pediatric cancer, can safely receive intravenous infusions of a reformulated mainstay of chemotherapy that has been delivered via painful intramuscular injection for more than 40 years, research suggests.

Tags: chemotherapy, ChildhoodCancer, Leukemia

  • Researchers at Dana-Farber/Children's Hospital Cancer Center have created a peptide that overcomes drug resistance and reactivates programmed cell death in recurrent blood cancers.

Tags: chemotherapy, DrugResistance, Leukemia, Lymphoma

Showing 1-10 of 17 items